An HDHP has: 1  A higher annual deductible than typical health plans, and. 2  A maximum limit on the sum of the annual deductible and out-of-pocket medical expenses that you must pay for covered expenses. Out-of-pocket expenses include copayments and other amounts, but donât include premiums.
Consumer Inquiries: 888-INFO-FDA. FDA approves first generic Lexapro to treat depression and anxiety disorder. The U.S. Food and Drug Administration today approved the first generic Lexapro (escitalopram tablets) to treat both depression and generalized anxiety disorder in adults. Depression is characterized by symptoms that interfere with a person's ability to work, sleep, study, eat, and enjoy once-pleasurable activities.
Which patents cover Relpax, and what generic alternatives are available? Relpax is a drug marketed by Pfizer Ireland and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge. This drug has one hundred and forty-seven patent family members in forty-six countries. The generic ingredient in RELPAX is eletriptan hydrobromide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the eletriptan hydrobromide profile page.